Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients

Helicobacter

Volumn 14, Issue 5, 2009, Pages 478-486

  Stec Michalska, Krystyna ^a   Peczek, Lukasz ^b   Michalski, Blazej ^a,b   Wisniewska Jarosinska, Maria ^a   Krakowiak, Agnieszka ^b   Nawrot, Barbara ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

CagA; FHIT; Gastric cancer; Helicobacter pylori; VacA

Indexed keywords

BACTERIAL DNA; FRAGILE HISTIDINE TRIAD PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOTOXICITY; DYSPEPSIA; FAMILY HISTORY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH CANCER; STOMACH MUCOSA; TUMOR SUPPRESSOR GENE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 70349096840     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00715.x     Document Type: Article

References (30)

1. Fitzgerald RC, Caldas C. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut 2004 53 : 775 778.
2. Rocco A, Schandl L, Chen J, Wang H, Tulassay Z, McNamara D, Malfertheiner P, Ebert MP. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer. J Cancer Res Clin Oncol 2003 129 (2 84 8.
3. Bragantini E, Barbi S, Beghelli S, Moore PS, de Manzoni G, Roviello F, Tomezzoli A, Vindigni C, Baffa R, Scarpa AJ. Loss of FHIT expression is associated with poorer survival in gastric cancer. J Cancer Res Clin Oncol 2006 132 : 45 50.
4. Pekarsky Y., Zanesi N., Palamarchuk A., Huebner K., Croce C.M. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 2002 3 : 748 754.
5. Koliopanos A, Avgerinos C, Paraskeva C, Touloumis Z, Kelgiorgi D, Dervenis C. Molecular aspects of carcinogenesis in pancreatic cancer. Hepatobiliary Pancreat Dis Int 2008 7 : 345 356.
6. Campiglio M., Bianchi F., Andriani F., Sozzi G., Tagliabue E., Ménard S., Roz L. Diadenosines as FHIT-ness instructors. J Cell Physiol 2006 208 : 274 281.
7. Ishii H., Ya Wang Y., Huebner K. A Fhit-ing Role in the DNA Damage Checkpoint Response. Cell Cycle 2007 6 : 1044 1048.
8. Ishii H, Zanesi N, Vecchione A, et al. Regression of upper gastric cancer in mice by FHIT gene delivery. FASEB J 2003 17 : 1768 1770.
9. Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of FHIT in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 1997 94 : 13771 13776.
10. Sozzi G, Pastorino U, Moiraghi L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998 58 : 5032 5037.
11. Stec-Michalska K, Antoszczyk S, Klupinska G, Nawrot B. Loss of FHIT Expression in the Gastric Mucosa of Patients with Family History of Gastric Cancer and Helicobacter pylori Infection. World J Gastroenterol 2005 11 : 17 21.
12. Soma T, Kaganoi J, Kawabe A, Kondo K, Imamura M, Shimada Y. Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells. Int J Cancer 2006 119 : 1023 1027.
13. Stec-Michalska K, Peczek L, Krakowiak A, Klupinska G, Chojnacki J, Michalski B, Nawrot B. Determination of the level of mRNA of fragile histidine triad (FHIT) protein in the gastric mucosa of cigarette smoking patients with nonulcear dyspepsia infected with Helicobacter pylori. Gastroenterologia Polska 2006 13 : 259 263.
14. Wirth T, Wang X, Linz B, Novick RP, Lum JK, Blaser M, Morelli G, Falush D, Achtman M. Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci USA 2004 101 : 4746 4751.
15. Miehlke S, Kirsch C, Agha-Amiri K, Günther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdörffer E. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 2000 87 : 322 327.
16. Ferreira AC, Isomoto H, Moriyama M, Fujioka T, Machado JC, Yamaoka Y. Helicobacter and gastric malignancies. Helicobacter 2008 13 (suppl 1 28 34.
17. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006 130 : 1377 1390.
18. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20 : 1161 1181.
19. Chattopadhyay S, Patra R, Ramamurthy T, Chowdhury A, Santra A, Dhali CK, Bhattacharya SK, Berg DE, Balakrish Nair G, Mukhopadhyay A. Multiplex PCR Assay for Rapid Detection and Genotyping of Helicobacter pylori Directly from Biopsy Specimens. J Clin Microbiol 2004 42 : 2821 2824.
20. Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K. Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinoma. Cancer Res 1998 58 : 3429 3434.
21. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNAmethylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998 72 : 141 196.
22. Leal MF, Lima EM, Silva PN, Assumpção PP, Calcagno DQ, Payão SL, Burbano RR, Smith MA. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil. World J Gastroenterol 2007 13 : 2568 2574.
23. Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 2005 96 : 835 843.
24. Pekarsky Y, Garrison PN, Palamarchuk A, Zanesi N, Aqeilan RI, Huebner K, Barnes LD, Croce CM. FHIT is a physiological target of the protein kinase Src. Proc Natl Acad Sci USA 2004 101 : 3775 3779.
25. Bianchi F, Magnifico A, Olgiati C, Zanesi N, Pekarsky Y, Tagliabue E, Croce CM, Menard S, Campiglio M. FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells. Proc Natl Acad Sci USA 2006 103 : 18981 18986.
26. Hara A, Yashima K, Yasugi A, Koda M, Kawaguchi K, Harada K, Andachi H, Shiota G, Ito H, Murawaki Y. Expression of FHIT, Mlh1, p16INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype. Oncol Rep 2007 18 : 553 559.
27. Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K, McCue PA. FHIT expression in gastric adenocarcinoma: correlation with disease stage and survival. Cancer 2000 88 : 24 34.
28. Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E. Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-1995. Int J Cancer 1999 83 : 743 749.
29. Bakir T, Can G, Siviloglu C, Erkul S. Gastric cancer and other organ cancer history in the parents of patients with gastric cancer. Eur J Cancer Prev 2003 12 : 183 189.
30. Ishii H, Dumon KR, Vecchione A, et al. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res 2001 61 : 1578 1584.